trade, and transport in advance of China’s Lunar New Year holiday season and because H7N9 seems to be following a more active winter seasonal pattern seen with other avian influenza viruses, the WHO said. Travel-associated cases could occur, but the agency said the ...
In February and September each year the World Health Organisation (WHO) recommends influenza viruses to be included in influenza vaccines for the forthcoming winters in the Northern and Southern Hemispheres respectively. These recommendations are based on data collected by National Influenza Centres (NIC...
“The influenza virus is changing constantly, and as a result, vaccine reformulation with strain changes is done every year to help keep up with the variation, which is why it is important we use real-world datasets to eva...
Safety and immunogenicity of H5N1 vaccine http://www.thelancet.com/…/PIIS0140-6736(06)69891-7/fulltext Child influenza vaccination: Ramifications of adverse events in children in Australia http://www.bmj.com/content/340/bmj.c2994 Progression of Renal Disease in Henoch-Schönlein Purpura Afte...
WHO’s influenza vaccine policy recommendations aim to protect vulnerable high-risk groups against severe influenza disease and death [1]. While many LMICs are anticipated to prioritize vaccines indicated for the prevention of severe influenza illness, additional considerations including maintaining a health...
Nucleoside analogues have been successfully used to treat viral DNA and RNA infections, such as HIV, hepatitis B virus, and several respiratory viruses, such as influenza [30,31,32,33,34]. Azvudine, as a nucleoside analogue, has been developed for the treatment of HIV, and its clinical ...
Barr IG. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine....
pertussis (whole cell) vaccine, plasma (human) for fractionation, rabies vaccine, and rotavirus vaccine. The report also provides a risk assessment and defines conditions for the safe production of pandemic strain influenza vaccines. The third part of the report provides information on the status an...
Food and Drug Administration in the next two to three weeks. The Pfizer vaccine will likely receive an EUA within days of a Dec. 10 advisory committee meeting that will study the vaccine and make recommendations to the FDA. The same group will meet Dec. 17 to s...
SAGE and EUL are complementary but independent processes. The EUL process is centered on determining if a manufactured product is quality-assured, safe and effective. SAGE is policy oriented. Policy recommendations for a vaccine are only of value to a vaccination cam...